CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention Infective Endocarditis After Transcatheter Aortic Valve Replacement Osteoarthritis risk is reduced after treatment with ticagrelor compared to clopidogrel: a propensity score matching analysis

Review Article2016 Dec;9(12).

JOURNAL:Circ Cardiovasc Interv. Article Link

Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials

Nerlekar N, Ha FJ, Brown AJ et al. Keywords: coronary angiography; coronary artery bypass; drug-eluting stent; meta-analysis; percutaneous coronary intervention

FULL TEXT PDF